NATACHA SMITH: Open Payments
NPI 1003298035 · NORCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 60 payments from 11 companies in 2025. Trend: 2023 $175 · 2024 $822 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 12 | $221 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $207 |
| Otsuka America Pharmaceutical, Inc. | 12 | $204 |
| Neurocrine BioSciences, Inc. | 8 | $146 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Lundbeck LLC | 2 | $59 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: Qelbree, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, Auvelity, SPRAVATO, VRAYLAR.
Industry payments across GA — which companies pay providers there.
